Pharmaceutical

Image

Global Herpangina Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Herpangina Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1.58 Billion
Diagram Market Size (Forecast Year) USD 2.50 Billion
Diagram CAGR %

Global Herpangina Treatment Market, By Virus (Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus), Symptoms (High Fever, Sore Throat, Blisters Or Ulcers In The Throat And Mouth, Difficulty Swallowing, Loss Of Appetite, Headache, Neck Pain, Swollen Lymph Glands), Treatment (Topical Anesthetics, Ibuprofen or Acetaminophen, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and Others) – Industry Trends and Forecast to 2030.

Herpangina Treatment Market Analysis and Size

Herpangina mainly affects toddlers and children younger than 10 years old. Newborns, people with compromised immune systems and ones who are pregnant are at a higher risk of getting an infection that could be dangerous or life-threatening. The viruses that cause herpangina are very contagious and survive in environments outside the body for long periods. Herpangina generally clears up after a week to 10 days.  

Data Bridge Market Research analyses a growth rate in the herpangina treatment market in the forecast period 2023-2030. The expected CAGR of the herpangina treatment market tend to be around 5.90% in the mentioned forecast period. The market was valued at USD 1.58 billion in 2022 and would grow to USD 2.5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Herpangina Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Virus (Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus), Symptoms (High Fever, Sore Throat, Blisters Or Ulcers In The Throat And Mouth , Difficulty Swallowing, Loss Of Appetite, Headache, Neck Pain, Swollen Lymph Glands), Treatment (Topical Anesthetics, Ibuprofen or Acetaminophen, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Hoffmann-La Roche Ltd. (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc (U.S.), AstraZeneca (U.K.), Abbvie, Inc. (U.S.), Bausch Health Companies Inc. (Canada), Bristol Myers Squibb Company (U.S.) GSK Plc. (U.K.), Mylan N.V. (U.S.), Novartis AG (Switzerland), AstraZeneca (U.K.), Gilead Sciences, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), Vertex Pharmaceuticals Incorporated (U.S.), ViiV Healthcare group of companies (U.S.), Sanofi (France), Mitsubishi Chemical Group Corporation (Japan)

Market Opportunities

  • Increasing Demand for Online Pharmacies
  • The emergence of new varied treatments

Market Definition

Herpangina is a type of infection that causes small blisters in mouth and throat, usually caused by a group of viruses known as enteroviruses. It is often misdiagnosed as another condition affecting children, called hand-foot-mouth disease (HFM). These both disorders cause oral blisters and ulcers but the location is slightly different. This infection is highly contagious and can easily spread person to person. This condition is not so common in adults as they have already built up the antibodies to fight the virus.

Herpangina Treatment Market Dynamics

Drivers

  • Increase in the number of R&D activities       

The market growth is boosted by an increase in the number of research activities. This will provide much beneficial opportunities for the market. The government is funding huge research and development (R&D) initiatives to encourage researchers and pharmaceutical companies to develop several novel medicines.

Opportunities

  • The emergence of new varied treatments

The new evolving research organizations in the market are equipped with and utilize the knowledge of professionals in numerous clinical disciplines, leading to important advances in understanding HTLV-1 -related disorders and treatment. Treatment methods such as Acetaminophen or ibuprofen for fever, topical anesthetics for sores in the mouth and throat.

  • Increasing Demand for Online Pharmacies

The rise in online access to medications and the rising culture of telemedicine and surge in the number of online pharmacies in developed countries create opportunities for market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

Restraints/Challenges

  • High Cost of Treatment Processes

The enormous expenditure required for the treatment processes impedes the market growth. Numerous market players make huge investments in developing new and advanced treatment procedures to faster the recovery process, and in return, the cost is increased.

This herpangina treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the herpangina treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Herpangina Treatment Market Scope

The herpangina treatment market is segmented on the basis of virus, symptoms, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Virus

  • Coxsackie Virus A
  • Coxsackie Virus B
  • Enterovirus 71
  • Echovirus

Symptoms

  • High Fever
  • Sore Throat
  • Blisters Or Ulcers In The Throat And Mouth
  • Difficulty Swallowing
  • Loss Of Appetite
  • Headache
  • Neck Pain
  • Swollen Lymph Glands

Treatment

  • Topical Anesthetics
  • Ibuprofen or Acetaminophen
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Herpangina Treatment Market Regional Analysis/Insights

The herpangina treatment market is analyzed and market size insights and trends are provided by virus, symptoms, treatment, distribution channel and end-user as referenced above.

The major countries covered in the herpangina treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period because of the rise in the prevalence of such disorders and favorable reimbursement scenario within the region.

Asia-Pacific is considered to grow over the coming years due to the rise in incidence of the disease and increase in expenditure on the prevention and diagnosis of infectious diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Herpangina Treatment Market Share Analysis

The herpangina treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to herpangina treatment market

Key players operating in the herpangina treatment market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc (U.S.)
  • AstraZeneca (U.K.)
  • Abbvie, Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Bristol Myers Squibb Company (U.S.)
  • GSK Plc. (U.K).
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Gilead Sciences, Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Merck & Co., Inc. (U.S.)
  • AbbVie Inc. (U.S.)
  • Vertex Pharmaceuticals Incorporated (U.S.)
  • ViiV Healthcare group of companies (U.S.)
  • Sanofi (France)
  • Mitsubishi Chemical Group Corporation (Japan)  


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The herpangina treatment market was USD 1.58 billion in 2022.
The herpangina treatment market is projected to grow at a CAGR of 5.90% during the forecast period of 2023-2030.
The herpangina treatment market report is segmented by Virus, Symptoms, Treatment, End-Users, Distribution Channel
North America is dominating the market in the forecast period because of the rise in the prevalence of such disorders and favorable reimbursement scenario within the region.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials